AMLX R&D Expenses
Amylyx Pharmaceuticals Inc · R&D Expenses
AMLX R&D Expenses
Latest reported$23.77Mperiod ending
AMLX Quarterly R&D Expenses ($5.01M → $23.77M)
Quarterly R&D Expenses
High-resolution chart · PNG
AMLX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 23,768,000 | |
| 27,610,000 | |
| 21,105,000 | |
| 19,855,000 | |
| 27,076,000 | |
| 22,119,000 | |
| 22,892,000 | |
| 21,237,000 | |
| 23,139,000 | |
| 36,608,000 | |
| 44,914,000 | |
| 30,037,000 | |
| 29,044,000 | |
| 24,192,000 | |
| 22,813,000 | |
| 24,914,000 | |
| 24,259,000 | |
| 21,464,000 | |
| 13,394,000 | |
| 12,853,000 | |
| 10,929,000 | |
| 6,864,000 | |
| 5,013,000 |